Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
A double-blind, European and U.S. Phase III trial in 152 adults with GHD showed that subcutaneous LB03002 met the primary endpoint of significantly reducing mean fat mass from baseline compared with p...